Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03551379 · ClinicalTrials.gov registry record
A Double Balloon Endoscopic Platform for ESD
A clinical trial of Colon Polyp and Colon Adenoma, sponsored by Lumendi.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT03551379 is a study of Colon Polyp and Colon Adenoma that has completed, run by Lumendi. The registered enrollment target is 15 participants, below the 158-participant average among 3 other Colon Polyp trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03551379, a study of Colon Polyp and Colon Adenoma, has completed, sponsored by Lumendi.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to record performance of a double balloon endolumenal interventional platform during complex colon polypectomy.
Conditions Studied
Interventions
- DEVICE Double Balloon Endoluminal Platform
Study Locations (1)
New York
- Winthrop-NYU Langone - Mineola
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-09-22 |
| Est. Completion | 2018-09-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03551379
The ClinicalTrials.gov registry entry for NCT03551379 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 158-participant average among 3 other Colon Polyp trials with a reported enrollment target (91% lower). The listed sponsor is Lumendi, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Colon Polyp appearing as the primary indexed condition, and to 1 intervention - of which Double Balloon Endoluminal Platform is the first listed.
NCT03551379 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03551379 about?
NCT03551379 is a clinical study titled "A Double Balloon Endoscopic Platform for ESD". The purpose of this observational study is to record performance of a double balloon endolumenal interventional platform during complex colon polypectomy.
What is the current status of trial NCT03551379?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2017-09-22. Estimated completion is 2018-09-29.
What conditions does trial NCT03551379 study?
This clinical trial studies the following conditions: Colon Polyp, Colon Adenoma.
What interventions are being tested in trial NCT03551379?
The interventions under investigation include: Double Balloon Endoluminal Platform (DEVICE).
Who is sponsoring clinical trial NCT03551379?
This trial is sponsored by Lumendi, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03551379 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colon Polyp
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.